Kolck Johannes, Hosse Clarissa, Fehrenbach Uli, Beetz Nick L, Auer Timo A, Pille Christian, Geisel Dominik
Department of Radiology, Charité, Berlin, Germany.
Berlin Institute of Health at Charité, Berlin, Germany.
Sci Rep. 2025 Jun 20;15(1):20176. doi: 10.1038/s41598-025-05912-2.
Muscle loss in critically ill patients, particularly during prolonged ICU stays, poses significant challenges to recovery and long-term outcomes. ICU-acquired weakness (ICUAW) manifests as severe muscle depletion, correlating with illness severity and hospitalization duration. This study aims to characterize long-term muscle loss trajectories in ICU patients with acute respiratory distress syndrome (ARDS) due to COVID-19 and severe acute pancreatitis (AP) and to explore contributing factors to elevated muscle decay. Retrospective cohort study including 154 ICU patients, 100 individuals suffering from AP and 54 from COVID-19 ARDS, who underwent a minimum of three CT scans during hospitalization, totaling 988 assessments. Sequential segmentation of psoas muscle area (PMA) was performed, and relative muscle loss per day for the entire monitoring period, as well as for the interval between each consecutive scan, was calculated. Bivariate and multivariate linear regression analyses were conducted to identify and evaluate the factors contributing to muscle loss. ICU patients experienced an average PMA decline of 46.0%, with a reduction of 41.8% observed in COVID-19 patients and 48.2% in AP patients. Notably, the long-term daily PMA loss was significantly greater in COVID-19 patients (1.88%) compared to AP patients (0.98%; p < 0.001). Linear regression analysis identified disease entity (p < 0.001), length of hospitalization (p < 0.001), and obesity as significant contributors to daily muscle deterioration. Patients admitted to the ICU for COVID-19 and severe AP can experience extreme muscle decay, reaching up to 48.2%. While decay rates vary considerably, COVID-19 patients experienced nearly twice the daily muscle loss compared to AP patients. Key factors contributing to muscle decay included disease entity, hospitalization duration, and obesity. These findings highlight the distinct impact of the underlying disease on muscle deterioration and emphasize the heightened risk for obese patients and those undergoing extended hospitalization.
重症患者的肌肉流失,尤其是在重症监护病房(ICU)长期住院期间,对康复和长期预后构成重大挑战。ICU获得性肌无力(ICUAW)表现为严重的肌肉消耗,与疾病严重程度和住院时间相关。本研究旨在描述因新冠病毒疾病(COVID-19)和重症急性胰腺炎(AP)导致急性呼吸窘迫综合征(ARDS)的ICU患者的长期肌肉流失轨迹,并探讨导致肌肉衰减加剧的因素。回顾性队列研究纳入了154名ICU患者,其中100例为AP患者,54例为COVID-19 ARDS患者,这些患者在住院期间至少接受了三次CT扫描,共计988次评估。对腰大肌面积(PMA)进行连续分割,并计算整个监测期以及每次连续扫描间隔期间的每日相对肌肉流失量。进行双变量和多变量线性回归分析,以识别和评估导致肌肉流失的因素。ICU患者的PMA平均下降46.0%,COVID-19患者下降41.8%,AP患者下降48.2%。值得注意的是,COVID-19患者的长期每日PMA流失(1.88%)显著高于AP患者(0.98%;p<0.001)。线性回归分析确定疾病类型(p<0.001)、住院时间(p<0.001)和肥胖是每日肌肉恶化的重要因素。因COVID-19和重症AP入住ICU的患者可能会出现极度肌肉衰减,高达48.2%。虽然衰减率差异很大,但COVID-19患者的每日肌肉流失量几乎是AP患者的两倍。导致肌肉衰减的关键因素包括疾病类型、住院时间和肥胖。这些发现突出了基础疾病对肌肉恶化的独特影响,并强调了肥胖患者和长期住院患者的高风险。